NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United+States Remove constraint Subjects: United+States

Search Results

8431. Considerations for the inclusion of adolescent patients in adult oncology clinical trials

8432. Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals

8433. Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products

8434. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff

8435. Pediatric HIV infection: drug product development for treatment

8436. Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis

8437. Interpretation of and compliance policy for certain label requirement: applicability of certain Federal Food, Drug, and Cosmetic Act requirements to vape shops

8438. Standards development and the use of standards in regulatory submissions reviewed in the Center for Biologics Evaluation and Research

8439. Pediatric information incorporated into human prescription drug and biological product labeling

8440. Recommended content and format of non-clinical bench performance testing information in premarket submissions: guidance for industry and Food and Drug Administration staff